Welcome to CDC stacks | Telomere length and age-at-menopause in the US - 36573 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Telomere length and age-at-menopause in the US
Filetype[PDF-497.19 KB]


Details:
  • Pubmed ID:
    26297686
  • Pubmed Central ID:
    PMC4669569
  • Description:
    Objectives

    Age-at-menopause and leukocyte telomere length (LTL) are both associated with biologic aging. Therefore, it would be reasonable to hypothesize that LTL may also serve as a marker for reproductive aging as shorter LTL may be associated with earlier age-at-menopause.

    Methods

    We analyzed data from 799 post-menopausal (ages 41–85) participants in the National Health and Nutrition Examination Survey (1999–2002), a nationally representative sample of U.S. women.

    Results

    Controlling for behavioral, socio-demographic, and health-related determinants of menopause, we found that among non-Hispanic white women, an increase of one standard deviation in LTL was associated with a 0.43 year higher reported age-at-menopause. Among Mexican–Americans, an increase of one standard deviation in LTL was associated with a 1.56 year earlier menopause. There was no significant association between LTL and age-at-menopause among non-Hispanic black women.

    Conclusions

    Our main finding is evidence of a strong interaction by race/ethnicity in the association between LTL and age-at-menopause. This evidence does not support the hypothesis that shorter LTL is a predictor of earlier age-at-menopause, as the magnitude and direction of the associations between LTL and age-at-menopause varied across racial/ethnic groups.

  • Document Type:
  • Collection(s):
  • Funding:
    CC999999/Intramural CDC HHS/United States
    R24 HD041041/HD/NICHD NIH HHS/United States
No Related Documents.
You May Also Like: